Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancer-Reference-Cited by-同舟云学术

Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancer

Published:2023-08-13 Issue:11 Volume:28 Page:1554-1562
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Kitazawa Shoko^ORCID,Chiyoda Tatsuyuki^ORCID,Nakamura Kohei^ORCID,Sakai Kensuke^ORCID,Yoshihama Tomoko^ORCID,Nishio Hiroshi^ORCID,Kobayashi Yusuke^ORCID,Iwata Takashi^ORCID,Banno Kouji^ORCID,Yamagami Wataru^ORCID,Nishihara Hiroshi^ORCID,Aoki Daisuke^ORCID

Funder

Japan Society for the Promotion of Science London

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

https://link.springer.com/content/pdf/10.1007/s10147-023-02398-8.pdf

Reference26 articles.

1. National Cancer Center, Japan. Cancer Information Services. https://www.ncc.go.jp/en/cis/index.html. Accessed 9 Jan 2023

2. Sunami K, Ichikawa H, Kubo T et al (2019) Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: a hospital-based study. Cancer Sci 110(4):1480–1490. https://doi.org/10.1111/cas.13969

3. Schram AM, Reales D, Galle J et al (2017) Oncologist use and perception of large panel next-generation tumor sequencing. Ann Oncol 28(9):2298–2304. https://doi.org/10.1093/annonc/mdx294

4. Aoyagi Y, Kano Y, Tohyama K et al (2022) Clinical utility of comprehensive genomic profiling in Japan: Result of PROFILE-F study. PLoS ONE 17(3):e0266112. https://doi.org/10.1371/journal.pone.0266112

5. Park HS, Lim SM, Kim S et al (2016) Pilot study of a next-generation sequencing-based targeted anticancer therapy in refractory solid tumors at a Korean Institution. PLoS ONE 11(4):e0154133. https://doi.org/10.1371/journal.pone.0154133

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Pathogenic Variants in Hereditary Cancer Syndromes in a Highly Heterogeneous Cohort of Patients: Insights from Multigene Analysis;Cancers;2023-12-23